TZDs inhibit the expression of TNF-α, IL-6, and resistin in adipose tissue, which promote insulin resistance and chronic inflammation16,17, while TZDs increased the production of adiponectin and fibroblast growth factor 21 (FGF21), which enhance fatty acid oxidation and insulin sensitivity18,19. The gene discussed is FGF21; the disease is Insulin resistance.